Search Results 681-690 of 17275 for Honey

1. A Phase 1b/2 Safety and Tolerability of MEDI6469 in Combination With Therapeutic Immune Agents or Monoclonal Antibodies - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

2. Wearable Technology for Health Monitoring in a Urological Patient Population. - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

3. High-dose Prophylactic Gabapentin (HOPE) Vs. Placebo To Prevent Opioid Use For Oral Mucositis Pain During Concurrent Chemoradiation For Head And Neck Cancer - Mayo Clinic

   About this study. This phase III trial tests if gabapentin can prevent the need for opiate pain medication for mouth sores (oral mucositis) in patients ...

4. Study Investigating the Impact on the Brain of Knock-outs, Technical Knock-outs and Chokes in Mixed Martial Arts - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

5. Cataracts - Diagnosis and treatment - Mayo Clinic

   Your eye doctor will ask questions about your health and medical history and do a thorough examination of your eyes. These tests can show whether you have ...

6. Study of Safety and Efficacy of Iberdomide (CC-220) and CC-99282 Combined With R-CHOP to Treat Lymphoma - Mayo Clinic

   About this study. The primary objective of Part 1 of this study is to define the maximum tolerated dose (MTD) and/or the recommended Phase 2 dose (RP2D) of ...

7. Giant Cell Arteritis Vessel Wall Enhancement - Mayo Clinic

   Also, to evaluate the association between ophthalmic artery and perineural optic nerve sheath enhancement on MRI and diagnosis and outcomes in GCA.

8. Trastuzumab Emtansine in Treating Older Patients With Human Epidermal Growth Factor Receptor 2-Positive Stage I-III Breast Cancer - Mayo Clinic

   Trastuzumab emtansine may kill cancer cells by binding to HER2-positive on the surface of the tumor cells and blocking their ability grow and spread.

9. Head and neck cancers - Doctors and departments - Mayo Clinic

   Learn about innovative treatment for throat cancers, mouth cancers, tongue cancers, tonsil cancers and other cancers that affect the head and neck.

10. A Study Using Botulinum Toxin Type A as Headache Prophylaxis in Adolescents with Chronic Migraine - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...